Literature DB >> 27113114

Long-Term PPI Use: Balancing Potential Harms and Documented Benefits.

Loren Laine1,2, Anil Nagar1,2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27113114     DOI: 10.1038/ajg.2016.156

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  29 in total

1.  Clopidogrel with or without omeprazole in coronary artery disease.

Authors:  Deepak L Bhatt; Byron L Cryer; Charles F Contant; Marc Cohen; Angel Lanas; Thomas J Schnitzer; Thomas L Shook; Pablo Lapuerta; Mark A Goldsmith; Loren Laine; Benjamin M Scirica; Sabina A Murphy; Christopher P Cannon
Journal:  N Engl J Med       Date:  2010-10-06       Impact factor: 91.245

2.  Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

Authors:  F K Chan; S C Chung; B Y Suen; Y T Lee; W K Leung; V K Leung; J C Wu; J Y Lau; Y Hui; M S Lai; H L Chan; J J Sung
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

3.  American Gastroenterological Association medical position statement: evaluation of dyspepsia.

Authors:  Nicholas J Talley
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

Review 4.  American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.

Authors:  Peter J Kahrilas; Nicholas J Shaheen; Michael F Vaezi
Journal:  Gastroenterology       Date:  2008-09-16       Impact factor: 22.682

5.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

6.  Guidelines for the management of dyspepsia.

Authors:  Nicholas J Talley; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

Review 7.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

8.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

9.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

Review 10.  Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Sushil Kumar Garg; Preet Paul Singh; Prasad G Iyer; Hashem B El-Serag
Journal:  Gut       Date:  2013-11-12       Impact factor: 23.059

View more
  11 in total

1.  Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy.

Authors:  Salva Balbale; Andrew Gawron; Sherri L LaVela
Journal:  Patient Exp J       Date:  2018

Review 2.  Potent Acid Suppression with PPIs and P-CABs: What's New?

Authors:  Richard H Hunt; Carmelo Scarpignato
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

3.  Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge.

Authors:  Verónica Gamelas; Vera Salvado; Luís Dias
Journal:  GE Port J Gastroenterol       Date:  2018-05-02

4.  Prescription Habits Related to Chronic Pathologies of Elderly People in Primary Care in the Western Part of Romania: Current Practices, International Recommendations, and Future Perspectives Regarding the Overuse and Misuse of Medicines.

Authors:  Valentina Buda; Andreea Prelipcean; Carmen Cristescu; Alexandru Roja; Olivia Dalleur; Minodora Andor; Corina Danciu; Adriana Ledeti; Cristina Adriana Dehelean; Octavian Cretu
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

5.  Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients.

Authors:  Jan Zirk-Sadowski; Jane A Masoli; W David Strain; Joao Delgado; William Henley; Willy Hamilton; David Melzer; Alessandro Ble
Journal:  Am J Gastroenterol       Date:  2017-03       Impact factor: 10.864

6.  Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients.

Authors:  Ya Qi Song; Yong Li; Su Li Zhang; Jie Gao; Shun Yi Feng
Journal:  PLoS One       Date:  2019-07-02       Impact factor: 3.240

7.  Association between the chronic use of gastric acid suppressants and high-risk colorectal polyps.

Authors:  Yasutoshi Shiratori; Takashi Ikeya; Naoki Ishii; Kazuki Yamamoto; Tetsuro Honda; Kenkei Hasatani; Naohiro Yoshida; Tsutomu Nishida; Tetsuya Sumiyoshi; Shu Kiyotoki; Masahiro Arai; Ryota Niikura
Journal:  JGH Open       Date:  2021-01-29

8.  Pharmacologic treatment of GERD in adolescents: Is esophageal mucosal protection an option?

Authors:  Claudio Romano; Carmelo Scarpignato
Journal:  Therap Adv Gastroenterol       Date:  2022-08-17       Impact factor: 4.802

9.  Internists' Perceptions of Proton Pump Inhibitor Adverse Effects and Impact on Prescribing Practices: Results of a Nationwide Survey.

Authors:  Jacob E Kurlander; Mark Kolbe; Joel H Rubenstein; Caroline R Richardson; Michele Heisler; Arlene Weissman; Raymond De Vries; Sameer D Saini
Journal:  Gastroenterology Res       Date:  2018-02-23

Review 10.  Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines.

Authors:  Hannah Saven; Lynna Zhong; Isabel M McFarlane
Journal:  Cureus       Date:  2022-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.